Baseline pain severity is associated with short-term pain reduction after intramuscular glucocorticoids; other clinical characteristics are not associated: a prospective cohort study
Clinical Rheumatology · 2026
DOI: 10.1007/s10067-026-08310-9 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Rheumatology, 2026. Verfasst von Sophie M Gerritsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Sint Maartenskliniek, Postbus 9011, Ubbergen, GM, 6500, the Netherlands. so.gerritsen@maartenskliniek.nl. Hauptthemen laut MEDLINE: Glucocorticoids, Osteoarthritis, Pain, Arthritis. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: Intramuscular (i.m.) glucocorticoids (GCs) are commonly prescribed in inflammatory arthritis (IA) and osteoarthritis (OA), yet prospective evidence on factors associated with treatment response remains limited. This study examined the association between baseline clinical characteristics and short-term (2 weeks) pain change following i.m. GC injections in IA and OA patients. METHOD: Our prospective cohort study (Sint Maartenskliniek, Nijmegen) included IA and OA patients receiving an i.m. GC injection between March and June 2024. Numeric Rating Scale (NRS) pain scores were assessed at baseline and at 2, 4, 6, and 12 weeks post-injection. The primary outcome was change in NRS pain at 2 weeks. Associations between baseline characteristics and treatment response measured by NRS pain change were analyzed using univariable and multivariable linear regression. RESULTS: Of 299 patients, 240 had available 2-week follow-up data. The median baseline NRS pain was 7 (95% CI, 6.7-7.3), decreasing to 4 (95% CI, 3.7-4.3) at 2 weeks (mean change, - 2.1; 95% CI, - 2.5 to - 1.7). Baseline NRS pain was the only significant predictor of response (β = - 0.516, p < 0.001). CONCLUSION: i.m. GCs administration was followed by a clinically relevant pain reduction in patients with IA and OA. Higher baseline NRS pain is the only factor associated with short-term pain change, whereas other baseline characteristics show no association. These findings suggest that commonly available clinical variables have limited value in explaining variation in short-term treatment response after i.m. GC injections. Key Points • Baseline NRS pain is the only factor associated with two-week pain improvement after intramuscular glucocorticoids • Other routinely collected clinical characteristics are not significantly associated with treatment response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Sint Maartenskliniek, Postbus 9011, Ubbergen, GM, 6500, the Netherlands. so.gerritsen@maartenskliniek.nl.
- Department of Research, Sint Maartenskliniek, Ubbergen, the Netherlands. so.gerritsen@maartenskliniek.nl.
- Department of Research, Sint Maartenskliniek, Ubbergen, the Netherlands.
- Department of Rheumatology, Sint Maartenskliniek, Postbus 9011, Ubbergen, GM, 6500, the Netherlands.
- Department of Rheumatology, Radboudumc, Nijmegen, the Netherlands.
- Department of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, the Netherlands.
Zitieren
APA
Gerritsen, S. M., Wientjes, M. H. M., Popa, C. D., van Herwaarden, N., & Cate, D. F. T. (2026). Baseline pain severity is associated with short-term pain reduction after intramuscular glucocorticoids; other clinical characteristics are not associated: a prospective cohort study. Clinical Rheumatology. https://doi.org/10.1007/s10067-026-08310-9
Vancouver
Gerritsen SM, Wientjes MHM, Popa CD, van Herwaarden N, Cate DFT. Baseline pain severity is associated with short-term pain reduction after intramuscular glucocorticoids; other clinical characteristics are not associated: a prospective cohort study. Clinical Rheumatology. 2026. doi:10.1007/s10067-026-08310-9
BibTeX
@article{Gerritsen2026,
author = {Gerritsen, Sophie M and Wientjes, Maike H M and Popa, Calin D and van Herwaarden, Noortje and Cate, David F Ten},
title = {Baseline pain severity is associated with short-term pain reduction after intramuscular glucocorticoids; other clinical characteristics are not associated: a prospective cohort study},
journal = {Clinical Rheumatology},
year = {2026},
doi = {10.1007/s10067-026-08310-9}
}
EUVIMED